Descrease article font size Increase article font size Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and …
A combined jab for flu and Covid triggered a stronger immune response than separate single vaccines, according to data released by Moderna. The results raise hopes the new vaccine could …
Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots …
Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines and its shares plummeted over 16% in …
Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to …
As autumn rolls in, health experts are giving the green light for Canadians to double up on their vaccinations, as getting both the flu and COVID-19 shots at the same …
Public health officials say the number of COVID-19 infections is climbing again — just in time for respiratory virus season in the fall and winter, when respiratory syncytial virus and …
Descrease article font size Increase article font size Health Canada has given the green light to an eagerly anticipated fall COVID-19 booster shot in hopes of bolstering the nation’s defence …
Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the highly mutated BA.2.86 subvariant of the coronavirus in …
Moderna announced Wednesday that its updated COVID-19 vaccine is effective against emerging variants of the virus, including the Pirola variant. The XBB.1.5 variant, also referred to as Kraken, has risen …